Etova-ER 400 Tablet PR
By Etova
Rx
10 Tablet PR in a Strip

Composition
Etodolac(400mg)

Manufacturer - Ipca Laboratories Ltd
142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra

Expires on or after
September, 2025

liver
Limited information is currently available regarding the use of Etova-ER 400 Tablet PR in individuals with liver disease. It is strongly recommended to seek advice from your healthcare provider before taking this medication if you have any liver-related concerns. Consulting with your doctor will help ensure the safe and appropriate use of Etova-ER 400 Tablet PR in relation to your liver health.

kidney
Etova-ER 400 Tablet PR is considered safe for patients with kidney disease. Consult your doctor as dose adjustment may not be necessary. Regular kidney function tests are recommended during treatment.

alcohol
It is unsafe to drink alcohol while taking Etova-ER 400 Tablet PR. Avoid alcohol to prevent potential health risks.

driving
Etova-ER 400 Tablet PR may cause drowsiness, dizziness, and blurred vision. Avoid driving if experiencing these effects.

pregnancy
Etova-ER 400 Tablet PR may be harmful during pregnancy based on animal studies. Consult your doctor as limited human studies suggest potential risks to the developing baby. Your doctor will assess the benefits and risks before prescribing this medication.

breastfeeding
Etova-ER 400 Tablet PR is not recommended during breastfeeding as it may pass into breastmilk and potentially harm the baby. It is better to consult your doctor before using this medication while breastfeeding.
Habit Forming | No |
Chemical Class | Indolyl Carboxylic Acids Derivatives |
Therapeutic Class | PAIN ANALGESICS |
Action Class | NSAID's- Non-Selective COX 1&2 Inhibitors (acetic acid) |
₹192.5
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025